NASDAQ:QNRX | Free Cash Flow | Quoin Pharmaceuticals, Ltd.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.87M
2025-12-31-$5.04M
2025-03-31-$2.59M
2024-12-31-$2.24M
2024-03-31-$1.43M
2023-12-31-$3.22M
2023-03-31-$1.75M
2022-12-31-$1.94M
2022-03-31-$2.09M
2021-12-31-$3.18M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$13.54M
2024-12-31-$7.86M
2023-12-31-$7.86M
2022-12-31-$8.48M
2021-12-31-$5.72M
2020-12-31-$1.34M
2019-12-31-$1.3M